NO996484L - Ny fremgangsmÕte for fremstilling av faste paroksetin- dispersjoner - Google Patents

Ny fremgangsmÕte for fremstilling av faste paroksetin- dispersjoner

Info

Publication number
NO996484L
NO996484L NO996484A NO996484A NO996484L NO 996484 L NO996484 L NO 996484L NO 996484 A NO996484 A NO 996484A NO 996484 A NO996484 A NO 996484A NO 996484 L NO996484 L NO 996484L
Authority
NO
Norway
Prior art keywords
dispersions
new process
preparing solid
solid paroxetine
paroxetine
Prior art date
Application number
NO996484A
Other languages
English (en)
Other versions
NO996484D0 (no
Inventor
Philip J Krape
Sou-Chan Chang
Ii William A Hein
Christopher A Teleha
Original Assignee
Endo Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endo Pharmaceuticals Inc filed Critical Endo Pharmaceuticals Inc
Publication of NO996484D0 publication Critical patent/NO996484D0/no
Publication of NO996484L publication Critical patent/NO996484L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO996484A 1997-06-30 1999-12-27 Ny fremgangsmÕte for fremstilling av faste paroksetin- dispersjoner NO996484L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/885,068 US5955475A (en) 1997-06-30 1997-06-30 Process for manufacturing paroxetine solid dispersions
PCT/US1998/013350 WO1999000131A1 (en) 1997-06-30 1998-06-26 Novel process for manufacturing paroxetine solid dispersions

Publications (2)

Publication Number Publication Date
NO996484D0 NO996484D0 (no) 1999-12-27
NO996484L true NO996484L (no) 2000-02-25

Family

ID=25386061

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996484A NO996484L (no) 1997-06-30 1999-12-27 Ny fremgangsmÕte for fremstilling av faste paroksetin- dispersjoner

Country Status (22)

Country Link
US (1) US5955475A (no)
EP (1) EP0991408B1 (no)
JP (1) JP2002514227A (no)
KR (1) KR100571044B1 (no)
CN (1) CN1121219C (no)
AP (1) AP9901725A0 (no)
AR (1) AR013131A1 (no)
AT (1) ATE290381T1 (no)
AU (1) AU733194B2 (no)
BR (1) BR9810231A (no)
CA (1) CA2295752C (no)
DE (1) DE69829286T2 (no)
ES (1) ES2239395T3 (no)
MA (1) MA24589A1 (no)
NO (1) NO996484L (no)
NZ (1) NZ502062A (no)
OA (1) OA11518A (no)
RU (1) RU2185820C2 (no)
SA (1) SA98190227A (no)
TR (1) TR199903315T2 (no)
WO (1) WO1999000131A1 (no)
ZA (1) ZA985488B (no)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638948B1 (en) * 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
KR100543614B1 (ko) * 1997-06-10 2006-01-20 신톤 비.브이. 4-페닐피페리딘 화합물
US6699882B2 (en) 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
US6168805B1 (en) * 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
WO2000054775A1 (de) * 1999-03-12 2000-09-21 Basf Ag Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
ES2290027T3 (es) * 1999-05-20 2008-02-16 Elan Corporation, Plc Formulaciones multiparticuladas y de liberacion controlada de inhibidores selectivos de la recaptacion de serotonina.
DE19930454A1 (de) * 1999-07-02 2001-01-04 Knoll Ag Feste Paroxetin enthaltende Zubereitungen
US6503927B1 (en) * 1999-10-28 2003-01-07 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
EP1175205B1 (en) * 1999-11-12 2006-06-14 Abbott Laboratories Solid dispersion comprising ritonavir, fenofibrate or griseofulvin
DE10000792A1 (de) * 2000-01-11 2001-07-19 Bernhard C Lippold Formulierungen von Wirkstoffen in Form einer festen Dispersion
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
ATE326949T1 (de) * 2000-03-09 2006-06-15 Univ Ohio State Res Found Verfahren zur herstellung fester dispersionen
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US6660298B1 (en) * 2000-07-27 2003-12-09 Pentech Pharmaceuticals, Inc. Paroxetine tablets and capsules
US7115279B2 (en) * 2000-08-03 2006-10-03 Curatolo William J Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
US20030212105A1 (en) * 2000-12-07 2003-11-13 Agrawal Shyam Sunder Novel anti-fertility agent
US6720003B2 (en) 2001-02-16 2004-04-13 Andrx Corporation Serotonin reuptake inhibitor formulations
WO2002085360A1 (en) * 2001-04-25 2002-10-31 Pentech Pharmaceuticals, Inc. Optimized procedures for the manufacture of paroxetine salts
PL368587A1 (en) * 2001-06-22 2005-04-04 Pfizer Products Inc. Pharmaceutical compositions comprising low-solubility and/or acid-sensitive drugs and neutralized acidic polymers
JP2004534811A (ja) * 2001-06-22 2004-11-18 ファイザー・プロダクツ・インク ポリマーと薬剤の集合体を含む医薬組成物
US20040225128A1 (en) * 2001-08-02 2004-11-11 Callewaert George Leo Paroxetine isethionate salt, process of preparation and use in the treatment of depression
EP1465601A4 (en) * 2001-12-28 2006-02-15 Teva Pharma STABLE PHARMACEUTICAL FORMULATION OF PAROXETINE ANHYDROUS HYDROCHLORIDE AND PREPARATION METHOD
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US20050266082A1 (en) * 2004-05-26 2005-12-01 Patel Satishkumar A Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
WO2006023347A1 (en) * 2004-08-20 2006-03-02 Alpharma, Inc. Paroxetine formulations
KR100691608B1 (ko) * 2005-02-21 2007-03-12 (주)나노하이브리드 염기성 고분자가 첨가된 유리 염기형 약물과 층상형 규산염의 하이브리드 및 그의 제조방법
WO2007003278A1 (en) * 2005-07-05 2007-01-11 Abbott-Gmbh & Co. Kg Composition and dosage form comprising a solid or semi-solid matrix
WO2007015270A2 (en) * 2005-08-02 2007-02-08 Lupin Limited Novel controlled release compositions of selective serotonin reuptake inhibitors
CA2629514A1 (en) * 2005-11-14 2007-05-24 Auspex Pharmaceuticals, Inc. Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
EP2112925A4 (en) * 2006-11-15 2013-01-09 Abbott Lab SOLID PHARMACEUTICAL DOSAGE FORMULATIONS
ZA200905094B (en) 2006-12-22 2010-09-29 Yuhan Corp Revaprazan-containing solid dispersion and process for the preparation thereof
US9138430B2 (en) * 2007-12-27 2015-09-22 Mylan Specialty L.P. Formulation and method for the release of paroxetine in the large intestine
JP5700367B2 (ja) * 2010-05-06 2015-04-15 高田製薬株式会社 パロキセチン含有フイルムコ−テイング経口製剤
EP2649989B1 (en) 2012-04-13 2017-10-18 King Saud University Method for preparing a solid dispersion, solid dispersion obtained thereby and use thereof
WO2014009970A2 (en) * 2012-07-09 2014-01-16 Hetero Research Foundation Linagliptin solid dispersion
US9381199B2 (en) 2012-07-09 2016-07-05 Hetero Research Foundation Linagliptin solid dispersion
WO2014013511A2 (en) * 2012-07-20 2014-01-23 Hetero Research Foundation Rufinamide solid dispersion
US9211290B2 (en) * 2012-12-31 2015-12-15 Noven Therapeutics, Llc Solid dispersions of amorphous paroxetine mesylate
CN110114063B (zh) * 2017-01-06 2022-01-11 广东东阳光药业有限公司 鲁拉西酮固体分散体及其制备方法
RU2698400C1 (ru) * 2018-12-17 2019-08-26 Георгий Сергеевич Немов Способ лечения депрессии у собак и кошек

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5147733B2 (no) * 1974-02-15 1976-12-16
US4933360A (en) * 1983-03-16 1990-06-12 Boehringer Ingelheim Pharmaceuticals, Inc. Novel chlorthalidone process and product
DD220225A5 (de) * 1983-03-16 1985-03-27 Boehringer Ingelheim Ltd Verfahren zur herstellung einer festkoerperdispersion von chlorthalidon
ES2058061T3 (es) * 1985-10-25 1994-11-01 Beecham Group Plc Derivado de piperidina, su preparacion y su uso como medicamento.
EP0580860B2 (en) * 1991-04-16 2004-12-15 Nippon Shinyaku Company, Limited Method of manufacturing solid dispersion
WO1993011749A1 (en) * 1991-12-18 1993-06-24 Warner-Lambert Company A process for the preparation of a solid dispersion
IT1274241B (it) * 1993-12-03 1997-07-15 Smithkline Beecham Farma Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
WO1996031197A1 (en) * 1995-04-03 1996-10-10 Abbott Laboratories Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation

Also Published As

Publication number Publication date
ATE290381T1 (de) 2005-03-15
KR100571044B1 (ko) 2006-04-13
AR013131A1 (es) 2000-12-13
CN1265593A (zh) 2000-09-06
NO996484D0 (no) 1999-12-27
AU8171798A (en) 1999-01-19
BR9810231A (pt) 2000-08-08
CA2295752C (en) 2004-10-26
AU733194B2 (en) 2001-05-10
DE69829286D1 (de) 2005-04-14
SA98190227A (ar) 2005-12-03
AP9901725A0 (en) 1999-12-31
KR20010020592A (ko) 2001-03-15
ZA985488B (en) 1999-04-22
ES2239395T3 (es) 2005-09-16
EP0991408A1 (en) 2000-04-12
HK1029529A1 (en) 2001-04-06
US5955475A (en) 1999-09-21
NZ502062A (en) 2001-10-26
EP0991408A4 (en) 2003-07-09
EP0991408B1 (en) 2005-03-09
CA2295752A1 (en) 1999-01-07
WO1999000131A1 (en) 1999-01-07
JP2002514227A (ja) 2002-05-14
TR199903315T2 (xx) 2000-09-21
RU2185820C2 (ru) 2002-07-27
MA24589A1 (fr) 1998-12-31
DE69829286T2 (de) 2006-01-12
CN1121219C (zh) 2003-09-17
OA11518A (en) 2004-02-04

Similar Documents

Publication Publication Date Title
NO996484L (no) Ny fremgangsmÕte for fremstilling av faste paroksetin- dispersjoner
NO20012162D0 (no) Fremgangsmåte til klargjöring av en brönnboring
HRP980240B1 (en) A new process for the preparation of a pharmacologically ve substance
NO994717D0 (no) FremgangsmÕte og maskin for fremstilling av fleraksiale fiberduker
NO970939D0 (no) Fremgangsmåte ved fremstilling av paroksetinhydrokloridanhydrat
FI974139A7 (fi) Menetelmä selluloosan modifioimiseksi
FI971620A0 (fi) Autentikointimenetelmä
ID28489A (id) Metode untuk membuat 4-karboksiamino-2-disubstitusi 1,2,3,4-tetrahidroquinolin
DE69800225D1 (de) Kapselmaschine
HUP0002105A3 (en) Method for preparing 1,1,1,3,3-pentachlorobutane
HUP0100640A3 (en) Process for the preparation of 1,4-dihydropyridines
NO20003625L (no) Ny fremgangsmÕte for fremstilling av et ketimin
FI965305L (fi) Menetelmä polymeeridispersioiden valmistamiseksi
FI973644L (fi) Uusi menetelmä 2,3-dihydrobentsofuranolijohdannaisten valmistamiseksi
HUP0001751A3 (en) A process for the preparation of 1,4,7,10-tetraazacyclododecane
NO306097B1 (no) Fremgangsmåte for fremstilling av en kölle
HUP0004503A3 (en) Process for the preparation of paroxetine hydrochloride
HUP0200187A3 (en) A process for the preparation of 1,4,7,10-tetraazacyclododecane
NO20010629D0 (no) Fremgangsmåte for fremstilling av en ikke-krystallinsk anhydratform av paroksetinhydroklorid
GB9803881D0 (en) Process for preparing a bitumen emulsion
FI951061L (fi) Polyesteridispersioita, menetelmä niiden valmistamiseksi
AU6481799A (en) Process for the preparation of paroxetine hydrochloride
AU1396400A (en) Process for the preparation of paroxetine hydrochloride
IS5523A (is) Aðferð til að framleiða ísóprópýl-metýl-[2-(3-n-própoxýfenoxý)-etýl]amín
FI991617L (fi) Menetelmä vasteen tuottamiseksi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application